GeneDx Holdings Co., Ltd.
The firm may even take part in a panel presentation on the World Orphan Medicines Congress highlighting the position of genome sequencing in advancing precision drugs.
STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a frontrunner in enabling improved well being outcomes by way of genomic insights, right now introduced that it’s a main healthcare expertise firm within the pharmaceutical trade. Announced strategic partnership with Komodo Health. trade. This new partnership will improve entry to GeneDx’s in depth anonymized uncommon illness dataset. This dataset is presently accessible by way of Komodo Health’s MapEnhance product, which incorporates knowledge from over 500,000 exomes, permitting biopharmaceutical corporations to tell drug pipelines and enhance medical trials. acquire entry to genetic insights that may assist speed up Registration.
“The partnership between GeneDx and Komodo Health is a milestone in advancing the understanding of uncommon illnesses and associated drug growth,” stated Melanie Duquette, GeneDx Chief Growth Officer. “Investment in drug discovery for uncommon illnesses continues to develop, and by making our knowledge extra simply accessible to the businesses on the forefront of those discoveries, we’re increasing entry to life-changing remedies. We wish to speed up it.”
GeneDx’s uncommon illness datasets are acknowledged for his or her depth and accuracy, making them a beneficial useful resource for biopharmaceutical corporations looking for to determine new therapeutic targets and optimize medical trial designs. As an professional companion of MapEnhance, GeneDx’s wealthy repository of anonymized genetic knowledge will now be accessible by way of Komodo’s end-to-end platform, serving to corporations unlock deeper insights into genetically primarily based illnesses and uncover new We assist speed up breakthrough remedies.
“By combining the facility of GeneDx’s genetic intelligence with Komodo’s complete, longitudinal affected person trajectory perspective, we goal to advance precision drugs and pave the best way to extra personalised remedies for sufferers. It shall be an enormous acceleration for companies,” stated General Brad Kelly. Komodo Health, MapEnhance Manager: “We are excited to welcome GeneDx to his MapEnhance household and assist our prospects extra rapidly uncover the advanced genetic foundation of illness.”
GeneDx continues to show its worth to biopharmaceutical corporations by way of its participation within the World Orphan Drug Congress, April 23-25 in Boston. At the convention, GeneDx will current a panel titled “Enabling Precision Medicine as a Standard of Care,” which can discover how genomic data can advance precision drugs from the laboratory, biopharmaceutical, and guardian views. contemplate totally different views. Additional panel particulars:
story continues
Realizing precision drugs as normal therapy
Thursday, April 25:1:00-1:40pm
Hall C, Theater 1: Diagnostic Truck
Speaker:
Amanda Singleton, MPH, ScM, CGC, Biopharma Partnership, GeneDx
Ben Willis, Director of Business Excellence, Egetis Therapeutics US
Effie Parks, Podcast Host and Director of Partnerships, Once Upon a Gene – CTNNB1
GeneDx offers custom-made options for biopharmaceutical companions throughout all phases of the drug growth cycle, from early analysis and growth to medical trial recruitment.
Search: Find clinicians and sufferers utilizing GeneDx’s unparalleled datasets.
Explore: Use medical genomic insights to tell the drug discovery course of and supply market insights for cohort builders.
Partners: Collaborative applications to extend entry, pace analysis, and affected person discovery
To be taught extra about alternatives to companion with GeneDx, please go to our web site or cease by the GeneDx sales space #613 on the World Orphan Drug Congress.
GeneDx Investor Information Contact: Investors@GeneDx.com
GeneDx Media Contact: Press@GeneDx.com
About Komodo Health
Komodo Health combines real-world knowledge with the trade’s most full view of affected person encounters, enterprise software program and machine studying that join the dots between particular person affected person journeys and large-scale well being outcomes. and a expertise platform firm creating new requirements in analytics. Komodo helps prospects unearth patient-centric insights at scale throughout life sciences, payers, suppliers, and builders. This means combining medical knowledge with superior algorithms and AI-powered software program options to tell decision-making, shut gaps in care, handle illness burden, and assist corporations create less expensive, value-driven options. We will enable you construct your medical system. For extra data, please go to Komodohealth.com.
Media Contact: media@komodohealth.com
